PHASE II STUDY DATA ON SAFETY AND EFFICACY OF GM-CSF/LEUKINE® IN MILD-TO-MODERATE ALZHEIMER'S DISEASE
- Resource Type
- Abstract
- Source
- In
Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2018 14(7) Supplement:P249-P249 - Subject
Oral Sessions: O1-12: Clinical: Novel Therapeutic Approaches for Neurodegenerative Disease - Language
- ISSN
- 1552-5260